Assistant Professor, Neurological Surgery, UCSF School of Medicine
Pathology
Dr. Joanna J. Phillips, MD
|
|
Give Review
Dr. Joanna J. Phillips works in the field of Pathology. She attended Perelman School of Medicine at the University of Pennsylvania. Joanna J. Phillips, MD is a published doctor. She has 55 publications published. The most current publication "Magnetic resonance analysis of malignant transformation in recurrent glioma."
Publications
- Magnetic resonance analysis of malignant transformation in recurrent glioma.
- Targeting a Plk1-controlled polarity checkpoint in therapy-resistant glioblastoma-propagating cells.
- Practical Molecular Pathology and Histopathology of Embryonal Tumors.
- Signals that regulate the oncogenic fate of neural stem cells and progenitors.
- SULF2, a heparan sulfate endosulfatase, is present in the blood of healthy individuals and increases in cirrhosis.
- A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas.
- Epidermal growth factor-like module containing mucin-like hormone receptor 2 expression in gliomas.
- Hyperpolarized [1-13C] glutamate: a metabolic imaging biomarker of IDH1 mutational status in glioma.
- Targeting Wee1 for the treatment of pediatric high-grade gliomas.
- Characterization of metabolites in infiltrating gliomas using ex vivo (1) H high-resolution magic angle spinning spectroscopy.
- A single-institution phase II trial of radiation, temozolomide, erlotinib, and bevacizumab for initial treatment of glioblastoma.
- Matrix regulators in neural stem cell functions.
- Frequent truncating mutations of STAG2 in bladder cancer.
- The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: a multi-inst...
- Non-invasive in vivo assessment of IDH1 mutational status in glioma.
- Current management of choroid plexus carcinomas.
- Na+/K+-ATPase β2-subunit (AMOG) expression abrogates invasion of glioblastoma-derived brain tumor-initiating cells.
- G-protein coupled receptor kinase (GRK)-5 regulates proliferation of glioblastoma-derived stem cells.
- Pilocytic astrocytomas of the optic nerve and their relation to pilocytic astrocytomas elsewhere in the central nervous system.
- Histone 3 Lysine 9 Trimethylation Is Differentially Associated With Isocitrate Dehydrogenase Mutations in Oligodendrogliomas and High-Grade Astrocytomas.
- Pyruvate kinase m2 expression, but not pyruvate kinase activity, is up-regulated in a grade-specific manner in human glioma.
- PDGFRA Amplification is Common in Pediatric and Adult High-Grade Astrocytomas and Identifies a Poor Prognostic Group in IDH1 Mutant Glioblastoma.
- Super-Resolution Track Density Imaging of Glioblastoma: Histopathologic Correlation.
- Proteoglycans and their roles in brain cancer.
- Comparison of DSC-MRI post-processing techniques in predicting microvascular histopathology in patients newly diagnosed with GBM.
- Diagnostic implications of IDH1-R132H and OLIG2 expression patterns in rare and challenging glioblastoma variants.
- Characterization of a diffuse intrinsic pontine glioma cell line: implications for future investigations and treatment.
- Increased microglia/macrophage gene expression in a subset of adult and pediatric astrocytomas.
- Evaluation of heterogeneous metabolic profile in an orthotopic human glioblastoma xenograft model using compressed sensing hyperpolarized 3D (13) C magnetic resonance ...
- VEGF Inhibits Tumor Cell Invasion and Mesenchymal Transition through a MET/VEGFR2 Complex.
- Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging.
- PTEN promoter methylation and activation of the PI3K/Akt/mTOR pathway in pediatric gliomas and influence on clinical outcome.
- Cooperative interactions of BRAFV600E kinase and CDKN2A locus deficiency in pediatric malignant astrocytoma as a basis for rational therapy.
- Magnetic Resonance of 2-Hydroxyglutarate in IDH1-Mutated Low-Grade Gliomas.
- Clinical Stratification of Glioblastoma Based on Alterations in Retinoblastoma Tumor Suppressor Protein (RB1) and Association With the Proneural Subtype.
- Detection of early response to temozolomide treatment in brain tumors using hyperpolarized (13) C MR metabolic imaging.
- Choline metabolism, proliferation, and angiogenesis in nonenhancing grades 2 and 3 astrocytoma.
- Ex vivo MR spectroscopic measure differentiates tumor from treatment effects in GBM.
- Pituicytoma: characterization of a unique neoplasm by histology, immunohistochemistry, ultrastructure, and array-based comparative genomic hybridization.
- Intratumoral therapy of glioblastoma multiforme using genetically engineered transferrin for drug delivery.
- Pleiotropic role for MYCN in medulloblastoma.
- Neurolisteriosis presenting as cervical myelitis in an immunocompetent patient.
- Dandy-Walker malformation complex: correlation between ultrasonographic diagnosis and postmortem neuropathology.
- Contributions of the viral genetic background and a single amino acid substitution in an immunodominant CD8+ T-cell epitope to murine coronavirus neurovirulence.
- Amino acid substitutions within the heptad repeat domain 1 of murine coronavirus spike protein restrict viral antigen spread in the central nervous system.
- Murine coronavirus spike glycoprotein mediates degree of viral spread, inflammation, and virus-induced immunopathology in the central nervous system.
- Glioma Cells with the IDH1 Mutation Modulate Metabolic Fractional Flux through Pyruvate Carboxylase.
- Measuring sulfatase expression and invasion in glioblastoma.
- Numerical chromosomal instability mediates susceptibility to radiation treatment.
- Metabolic Reprogramming in Mutant IDH1 Glioma Cells.
- Proportional Upregulation of CD97 Isoforms in Glioblastoma and Glioblastoma-Derived Brain Tumor Initiating Cells.
- Glycosylation alterations in lung and brain cancer.
- PKM2 uses control of HuR localization to regulate p27 and cell cycle progression in human glioblastoma cells.
- MR Studies of Glioblastoma Models Treated with Dual PI3K/mTOR Inhibitor and Temozolomide - Metabolic Changes are Associated with Enhanced Survival.
Schools
Perelman School of Medicine University of Pennsylvania
Doctors Specialties
- Neuropathology
- Pathology
Accepted Insurances
Education
-
UCSF -
University of Washington -
Perelman School of Medicine at the University of Pennsylvania
Hospital
-
UCSF Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Judith A. Doyle, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sarah C. Cherny, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Junming Fang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew W. Bollen, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Philip E. Leboit, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Han S. Lee, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arie Perry, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gerald L. Schall, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tarik Tihan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ross M. Stein, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anne E. Hiniker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Gerald F. Reis
This Doctor is OpenDoctor Recommended.
|